Relay Therapeutics Cash Flow Statement (2019-2026) | RLAY

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-193.74M-61.92M-73.44M-80.07M-92.41M-85.28M-75.06M-100.57M-112.41M-74.27M-89.27M-82.71M-93.56M-88.39M-484.87M-77.97M-73.98M-74.22M-35.09M-79.13M
Depreciation and Depletion (Quarter)
0.96M1.01M1.01M0.97M0.96M1.03M1.17M1.20M1.33M1.36M1.38M1.40M1.37M1.37M1.33M1.21M1.00M0.75M0.60M0.50M
Share-based Compensation (Quarter)
16.15M12.42M1.20M13.46M15.15M13.72M9.51M21.52M23.41M21.84M19.27M27.19M15.62M11.08M17.64M19.32M9.31M9.53M-42.44M10.54M
Gains from Investment Securities (Quarter)
0.84M-4.59M
Cash from Operations (Quarter)
-28.14M-53.20M-39.71M-49.17M-57.09M-66.14M-57.08M-67.13M-68.60M-75.40M-89.19M-50.32M-65.83M-75.08M-57.87M-73.21M-55.26M-62.12M-44.87M-51.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.55M-0.67M-0.68M-0.68M-0.55M-0.34M0.39M2.02M2.20M2.88M3.67M3.67M3.29M3.18M2.18M1.60M1.39M1.10M0.86M0.78M
Depreciation & Amortization (CF) (Quarter)
0.96M1.01M1.01M0.97M0.96M1.03M1.17M1.20M1.33M1.36M1.38M1.40M1.37M1.37M1.33M1.21M1.00M0.75M0.60M0.50M
Change in Working Capital
Change in Receivables (Quarter)
0.20M0.53M-0.40M-0.13M0.02M-0.05M0.07M-0.02M-0.21M0.13M-0.21M
Change in Account Payables (Quarter)
-0.06M-0.64M2.43M-1.22M-3.39M4.63M1.97M1.40M2.80M-1.22M-5.37M0.10M3.21M-4.30M
Change in Accured Expenses (Quarter)
5.20M4.82M7.92M3.05M6.49M17.89M-16.67M5.59M-1.51M-19.52M5.84M0.46M15.96M1.14M-7.29M-0.31M-1.07M0.47M-0.61M3.67M
Investing Activities
Capital Expenditures (Quarter)
0.60M-1.04M3.44M2.79M1.86M2.10M2.32M1.92M1.50M0.59M0.12M1.78M0.01M0.23M0.38M0.03M-0.00M0.00M
Acquisitions (Quarter)
0.08M0.08M
Change in Acquisitions & Divestments (Quarter)
78.50M30.00M35.25M18.10M69.50M85.11M183.02M175.04M118.94M156.71M196.61M203.09M165.19M139.20M104.07M64.82M84.10M97.80M69.46M83.80M
Cash from Investing Activities (Quarter)
26.07M20.79M-292.75M-112.38M43.39M27.19M-146.94M75.31M51.28M71.36M59.68M10.53M45.55M-126.16M29.00M42.47M75.15M39.73M35.46M32.90M
Financing Activities
Other financing activities (Quarter)
0.55M
Change in Capital Stock
Shares Issued (Quarter)
1.81M1.77M12.39M1.56M9.33M
Net Equity Issued and Repurchased (Quarter)
1.12M0.90M0.66M0.88M0.86M284.70M9.40M17.90M218.20M
Misc.
Cash from Financing Activities (Quarter)
1.12M0.90M384.01M0.88M2.00M285.87M1.17M1.30M2.08M9.46M21.92M48.92M1.54M218.89M0.80M0.02M0.93M138.78M
Change in Cash (Quarter)
-0.95M-31.51M51.56M-160.67M-11.71M246.91M-202.85M9.48M-15.24M5.43M-7.59M9.13M-18.74M17.64M-28.07M-30.75M20.54M-22.38M-8.47M120.57M
Free Cash Flow (Quarter)
-28.74M-52.16M-43.15M-51.97M-58.95M-68.24M-59.40M-69.05M-70.10M-75.99M-89.31M-52.10M-65.84M-75.31M-57.87M-73.59M-55.29M-62.12M-44.87M-51.11M
Net Cash Flow (Quarter)
-0.95M-31.51M51.56M-160.67M-11.71M246.91M-202.85M9.48M-15.24M5.43M-7.59M9.13M-18.74M17.64M-28.07M-30.75M19.89M-22.38M-8.47M120.57M